XML 54 R38.htm IDEA: XBRL DOCUMENT v3.4.0.3
Acquisitions - Narrative (Details) - Synageva BioPharma Corp. - USD ($)
Jun. 22, 2015
May. 06, 2015
May. 05, 2015
Business Acquisition [Line Items]      
Cash consideration $ 4,565,524,000    
Number of shares (shares) 26,125,000    
Consideration transferred, net of cash acquired $ 8,860,000,000    
Share price (dollars per share) $ 188.24    
Inventory $ 23,880,000    
Intangible assets $ 4,236,000,000    
Weighted average cost of capital (percent) 10.00%    
Deferred tax liabilities, net $ 171,638,000    
Deferred tax liabilities, net 602,887,000    
Deferred tax assets, net $ 431,249,000    
Scenario, Previously Reported      
Business Acquisition [Line Items]      
Cash consideration   $ 115  
Number of shares (shares)   0.6581  
Consideration transferred, net of cash acquired   $ 8,400,000,000  
Share price (dollars per share)     $ 168.55